Clinical Trial Update: Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing non-inferiority and 5-year persistence for GSK Hib-MenC in toddlers across Haemophilus influenzae type b and Neisseria m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Disease
• Neisseria Meningitidis Disease

Drugs mentioned

• GSK Hib-MenC
• Hib-MenC (Haemophilus influenzae type b and Neisseria meningitidis conjugate vaccine (Hib-MenC))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Haemophilus Influenzae Type b, Neisseria Meningitidis | Phase 3 | Status: COMPLETED | Results posted: 2009-10-23